A randomized, double-blind, placebo controlled, parallel group clinical study investigating the analgesic effect and safety of a topical formulation of lidocaine (SHACT) during and after insertion of an Intra Uterine Device. A phase II study.

Trial Profile

A randomized, double-blind, placebo controlled, parallel group clinical study investigating the analgesic effect and safety of a topical formulation of lidocaine (SHACT) during and after insertion of an Intra Uterine Device. A phase II study.

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Feb 2015

At a glance

  • Drugs Lidocaine (Primary)
  • Indications Procedural pain
  • Focus Therapeutic Use
  • Sponsors Pharmanest
  • Most Recent Events

    • 02 Aug 2013 Karolinska Development AB announce positive results of this trial in a media release.
    • 02 Aug 2013 Primary endpoint 'Pain-intensity' has been met, accordign to a Karolinska Development media release.
    • 02 Aug 2013 Status changed from recruiting to completed; assumed based on the media release from Karolinska Development.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top